Inhibition of GSK3β enhances both adhesive and signalling activities of β‐catenin in mouse embryonic stem cells
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Background. GSK3β (glycogen synthase kinase 3β) regulates the expression level and activity of various target proteins, including β‐catenin. β‐Catenin is a co‐activator of Wnt‐dependent genes as well as a partner for transmembrane cadherins to mediate cell‐to‐cell adhesion. In some cases, inhibition of GSK3β activity was shown to promote self‐renewal of ESCs (embryonic stem cells), but immediate effects of GSK3β inhibitors in these cells still remain elusive. Results. Here, we address the effects of GSK3β inhibitors BIO (6‐bromoindirubin‐3′‐oxime) and CHIR99021 on mESCs (mouse ESCs), focusing on modulation of β‐catenin activities. We found that, upon GSK3β inhibition, the colonies of undifferentiated mESCs acquire a more compact morphology. This change is paralleled by two somewhat polar effects: (i) the accumulation of the β‐catenin, which is co‐localized with E‐cadherin at the plasma membrane, and the cytoplasmic, tyrosine unphosphorylated β‐catenin, which is able to bind the GST (glutathione transferase)‐fused cytoplasmic domain of E‐cadherin; and (ii) the accumulation of the tyrosine phosphorylated β‐catenin and its nuclear translocation that is accompanied by activation of the Tcf (T‐cell factor)/β‐catenin‐dependent transcription of Top‐Flash reporter. The Tcf‐mediated activation, however, does not affect most of the analysed Wnt‐responsive genes involved in EMT (epithelial—mesenchymal transition) or cell‐cycle progression, suggesting that the adhesive function of β‐catenin is dominant over transcription in undifferentiated mESCs. Treatment with BIO decreases proliferation rates of mESCs. This is not due to apoptosis, but rather to accumulation of cells in G 1 phase of the cell cycle and is accompanied by down‐regulation of the c‐myc mRNA content. Conclusion. Our results suggest that inhibition of GSK3β activity in mESCs enhances both the β‐catenin/E‐cadherin‐mediated adhesion and the Tcf/β‐catenin‐dependent transcription, but does not activate transcription in most of the examined genes involved in EMT and cell cycle progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The ground state of embryonic stem cell self-renewal
Ying, Q.-L., Wray, J., Nichols, J., Batlle-Morera, L., Doble, B., Woodgett, J., Cohen, P., & Smith, A. (2008) · Nature · doi:10.1038/nature06968 · Cited by 3,442 · cited 6×
“To block GSK3β we treated the cells with the inhibitors BIO (6- bromoindirubin-3′-oxime) and CHIR99021, both previously used in ESCs studies (Sato et al., 2004; Ying et al., 2008).”
BackgroundMethodInfluentialE-cadherin null mutant embryos fail to form a trophectoderm epithelium.
Larue, L., Ohsugi, M., Hirchenhain, J., & Kemler, R. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.17.8263 · Cited by 930 · cited 1×
“In the course of pre-implantation development, β-catenin–E-cadherin contacts are crucial for proper compaction and blastocyst formation (Larue et al., 1994).”
BackgroundRimm, D. L., Koslov, E. R., Kebriaei, P., Cianci, C. D., & Morrow, J. S. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.19.8813 · Cited by 735
Cited by
Small-Molecule-Driven Hepatocyte Differentiation of Human Pluripotent Stem Cells
Siller, R., Greenhough, S., Naumovska, E., & Sullivan, G. J. (2015) · Stem Cell Reports · doi:10.1016/j.stemcr.2015.04.001 · Cited by 203
“…BIO and CHIR99021 are potent pharmacological GSK3-specific inhibitors that result in activation of the Wnt signaling pathway (Sato et al., 2004; Sineva and Pospelov, 2010), so we next assessed the ability of the protein Wnt3a alone to drive differentiation toward DE. Figure 2C demonstrates…”
BackgroundFang, L., Zhu, Q., Neuenschwander, M., Specker, E., Wulf-Goldenberg, A., Weis, W. I., von Kries, J. P., & Birchmeier, W. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1519 · Cited by 190
Röttinger, E., Dahlin, P., & Martindale, M. Q. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1003164 · Cited by 140
Nakaoka, H., Gurumurthy, A., Hayano, T., Ahmadloo, S., Omer, W. H., Yoshihara, K., Yamamoto, A., Kurose, K., Enomoto, T., Akira, S., et al. (2016) · PLOS Genetics · doi:10.1371/journal.pgen.1005893 · Cited by 46
An ongoing role for Wnt signaling in differentiating melanocytes in vivo
Vibert, L., Aquino, G., Gehring, I., Subkankulova, T., Schilling, T. F., Rocco, A., & Kelsh, R. N. (2017) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12568 · Cited by 35
“…systems, including mammalian cardiomyocyte cell culture, melanoma cells (B16-F0), normal human melanocyte (NHM) cells, mouse embryonic stem cells, and zebrafish (Alexander et al., 2014; Bellei et al., 2008, 2010; Kim et al., 2010; Moro et al., 2012; Sineva and Pospelov, 2010; Tseng et al., 2006).”
Background
Metadata
- Authors
- Sineva, G. S., & Pospelov, V. A.
- Venue
- Biology of the Cell
- Publisher
- Wiley
- Published
- 2010-10
- Volume
- 102
- Issue
- 10
- Pages
- 549-564
- ISSN
- 0248-4900 (ISSN-L)
- 1768-322X
- OpenAlex
- W1970295705
- Cited by
- 67
- References
- 3
- FWCI
- 2.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.